SIP
WST icon

Stoneridge Investment Partners’s West Pharmaceutical WST Stock Holding History

Stoneridge Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
+1,233
New +$377K 0.28% 114
2017
Q2 		– Sell
-18,804
Closed -$1.53M – 317
2017
Q1 		$1.53M Buy
+18,804
New +$1.57M 0.21% 143

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Stoneridge Investment Partners's WST Position: Q2 2026 in Review

Stoneridge Investment Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,233 shares worth $420K. The stake represents 0.28% of the portfolio and ranks #114 among its holdings. This is a return to the name: Stoneridge Investment Partners previously reported a position in WST as recently as Q1 2017.

Stoneridge Investment Partners first reported a position in WST in Q1 2017 and has held it in 2 quarters since. The position peaked at $1.53M in Q1 2017. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Stoneridge Investment Partners held 1,233 shares of West Pharmaceutical worth $420K as of Q2 2026.
  • West Pharmaceutical was a new Stoneridge Investment Partners position in Q2 2026.
  • West Pharmaceutical made up 0.28% of Stoneridge Investment Partners's portfolio in Q2 2026, its #114 holding.
  • Stoneridge Investment Partners first reported a position in West Pharmaceutical in Q1 2017 and has held it in 2 quarters since.
  • Stoneridge Investment Partners's West Pharmaceutical position peaked at $1.53M in Q1 2017.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.